This searchable list includes the abstracts of all presentations given at a conference organised as part of the SENS series. We regret that the videos recorded at SENS3 and SENS4 are currently unavailable.
Using our knowledge of tumour immunology and genetic technology to treat cancer is now a realistic possibility. There are a variety of potential approaches but adoptive transfer of tumour-specific T cells is currently the most effective and has been successful in treating advanced melanomas. To extend this to other cancers and to simplify the process for clinical use, Engineered T cells (gene modified T cells artificially endowed with anti-cancer specificity) have been developed.Keywords: cancer immunotherapy, T cells, retrovirus, autoimmunity,